Business Standard

Granules, Amneal Pharma get FDA nod

Our Regional Bureau  |  Chennai/ Hyderabad 

India Limited and of the United States have received the approval for their tablets of 500 mg, 850 mg and 1000 mg.
 
This is the first time that the USFDA has approved an ANDA with a PFI (pharmaceutical formulation intermediate)-drug master file ( DMF) as a raw material, the companies claimed in a press release here on Tuesday.
 
The PFI concept of India involves preparing a 'ready-to-compress' mix of active pharmaceutical ingredients and excipients which can then be directly fed into a hopper for compression of tablets.
 
"This development has helped us being recognised as more than an over-the-counter player and has opened up a new vista of business opportunities for India," the company's managing director, Krishna Prasad, stated.

 
 

RECOMMENDED FOR YOU

Granules, Amneal Pharma get FDA nod

Granules India Limited and Amneal Pharmaceuticals LLC of the United States have received the approval for their abbreviated new drug application (ANDA) of Metformin Hydrochloride tablets of 500 mg,
India Limited and of the United States have received the approval for their tablets of 500 mg, 850 mg and 1000 mg.
 
This is the first time that the USFDA has approved an ANDA with a PFI (pharmaceutical formulation intermediate)-drug master file ( DMF) as a raw material, the companies claimed in a press release here on Tuesday.
 
The PFI concept of India involves preparing a 'ready-to-compress' mix of active pharmaceutical ingredients and excipients which can then be directly fed into a hopper for compression of tablets.
 
"This development has helped us being recognised as more than an over-the-counter player and has opened up a new vista of business opportunities for India," the company's managing director, Krishna Prasad, stated.

 
 
image
Business Standard
177 22

Granules, Amneal Pharma get FDA nod

India Limited and of the United States have received the approval for their tablets of 500 mg, 850 mg and 1000 mg.
 
This is the first time that the USFDA has approved an ANDA with a PFI (pharmaceutical formulation intermediate)-drug master file ( DMF) as a raw material, the companies claimed in a press release here on Tuesday.
 
The PFI concept of India involves preparing a 'ready-to-compress' mix of active pharmaceutical ingredients and excipients which can then be directly fed into a hopper for compression of tablets.
 
"This development has helped us being recognised as more than an over-the-counter player and has opened up a new vista of business opportunities for India," the company's managing director, Krishna Prasad, stated.

 
 

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard